当前位置:首页 - 行情中心 - 达安基因(002030) - 财务分析 - 现金流量表

达安基因

(002030)

  

流通市值:72.84亿  总市值:72.84亿
流通股本:14.03亿   总股本:14.03亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金733,683,619.36458,213,148.82209,327,655.561,237,264,874.67
  收到的税费返还538,852.29396,286.82150,359.32644,902.39
  收到其他与经营活动有关的现金256,123,269.8183,175,255.78103,371,358.66663,271,502.58
  经营活动现金流入小计990,345,741.45641,784,691.42312,849,373.541,901,181,279.64
  购买商品、接受劳务支付的现金253,237,640.44159,824,461.1188,984,150.74461,754,432.73
  支付给职工以及为职工支付的现金283,485,491.12212,340,993128,099,894.38363,597,158.34
  支付的各项税费18,281,769.4813,718,114.266,468,338.3529,802,684.74
  支付其他与经营活动有关的现金323,338,285.26230,217,387.13134,930,638.11726,537,750.47
  经营活动现金流出小计878,343,186.3616,100,955.5358,483,021.581,581,692,026.28
  经营活动产生的现金流量净额112,002,555.1525,683,735.92-45,633,648.04319,489,253.36
二、投资活动产生的现金流量:
  收回投资收到的现金1,577,417,982.711,096,082,000269,082,0001,095,884,805.06
  取得投资收益收到的现金28,800,271.1324,822,613.712,128,399.0429,676,851.6
  处置固定资产、无形资产和其他长期资产收回的现金净额11,162.1700424,655.96
  收到的其他与投资活动有关的现金82,372,50082,372,50038,412,500732,791,710.66
  投资活动现金流入小计1,688,601,916.011,203,277,113.71309,622,899.041,858,778,023.28
  购建固定资产、无形资产和其他长期资产支付的现金42,774,001.817,310,726.828,798,807.78238,999,279.14
  投资支付的现金1,357,560,0001,055,560,000263,560,0001,632,290,379.04
  支付其他与投资活动有关的现金70,000,00070,000,0000624,806,188.61
  投资活动现金流出小计1,470,334,001.81,142,870,726.82272,358,807.782,496,095,846.79
  投资活动产生的现金流量净额218,267,914.2160,406,386.8937,264,091.26-637,317,823.51
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,460,800500,000500,0000
  其中:子公司吸收少数股东投资收到的现金0500,000500,0000
  取得借款收到的现金69,226,993.5354,976,993.5348,979,000123,008,582.28
  收到其他与筹资活动有关的现金0004,902,171.33
  筹资活动现金流入小计70,687,793.5355,476,993.5349,479,000127,910,753.61
  偿还债务支付的现金84,852,763.0960,071,190.532,017,056.5158,049,036
  分配股利、利润或偿付利息支付的现金3,526,602.672,374,096.351,185,655.368,457,272.67
  支付其他与筹资活动有关的现金2,368,622.842,030,197.09360,718.795,958,076.35
  筹资活动现金流出小计90,747,988.664,475,483.9433,563,430.65172,464,385.02
  筹资活动产生的现金流量净额-20,060,195.07-8,998,490.4115,915,569.35-44,553,631.41
四、汇率变动对现金及现金等价物的影响-1,891,766.13-1,410,104.33-720,604.91-1,331,249.4
五、现金及现金等价物净增加额308,318,508.1675,681,528.076,825,407.66-363,713,450.96
  加:期初现金及现金等价物余额503,658,427.3503,658,427.3503,658,427.3867,371,878.26
  期末现金及现金等价物余额811,976,935.46579,339,955.37510,483,834.96503,658,427.3
补充资料:
  净利润--124,465,953.27--780,521,960.65
  资产减值准备-2,244,215.45-436,991,981.1
  固定资产和投资性房地产折旧-41,879,386.14-148,169,554.51
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-41,879,386.14-148,169,554.51
  无形资产摊销-60,762,124.61-142,837,743.93
  长期待摊费用摊销-24,188,311.17-20,199,265.52
  处置固定资产、无形资产和其他长期资产的损失-3,759.71--5,476,467.27
  固定资产报废损失-566,991.84-5,351,082.78
  公允价值变动损失-103,232,310.4--4,572,082.42
  财务费用--6,270,832.6-4,185,770.56
  投资损失--21,026,636.05--49,428,681.35
  递延所得税--12,175,447.36-16,677,417.29
  其中:递延所得税资产减少--752,776.01-14,036,475.42
    递延所得税负债增加--11,422,671.35-2,640,941.87
  存货的减少-3,839,438.93-41,271,030.36
  经营性应收项目的减少-84,241,399.58-398,866,558.38
  经营性应付项目的增加--91,212,116.14--178,571,032.01
  其他-0-0
  债务转为资本-0-0
  一年内到期的可转换公司债券-0-0
  融资租入固定资产-0-0
  不涉及现金收支的投资和筹资活动金额其他项目---4,436,208.16
  现金的期末余额-579,339,955.37-503,658,427.3
  减:现金的期初余额-503,658,427.3-867,371,878.26
  加:现金等价物的期末余额-0-0
  减:现金等价物的期初余额-0-0
  现金及现金等价物的净增加额-75,681,528.07--363,713,450.96
公告日期2026-10-262026-08-292026-04-282026-04-28
审计意见(境内)标准无保留意见
TOP↑